ArticleCureus2026
Surgical Treatment for an Infectious Aneurysm Caused by Perclose ProGlide®: A Case Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, there has been a shift from the inguinal approach to coronary artery treatment to the radial approach, which has fewer complications. However, the inguinal approach is still often used in cases of dialysis. Following inguinal puncture, vascular closure devices (VCDs) such as ANGIO-SEAL® (Terumo, Tokyo, Japan), EXOSEAL® (Hialeah, Miami Lakes, FL), and Perclose ProGlide® (Abbott Vascular Device, Santa Clara, CA) are used according to their various characteristics. In this report, a 61-year-old male patient supported by maintenance dialysis underwent a medical examination, whereupon an abnormal electrocardiogram was produced. When a catheter was then implemented, three-vessel disease was found, and coronary artery bypass grafting (CABG) was recommended. However, upon the patient's request, percutaneous coronary transluminal angioplasty (PTCA) was instead performed. The patient underwent coronary artery treatment across three sessions; in the third session, an approach from the right inguinal region was taken, and Perclose ProGlide® was used for vascular closure following treatment. However, paralysis of the right lower limb occurred four days later, and the patient returned to our department, where he was found to have high inflammation levels, methicillin-susceptible
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.